DIANA LIAW: Open Payments
NPI 1770250599 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 14 payments from 9 companies in 2025. Trend: 2023 $195 · 2024 $107 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 5 | $236 |
| SCPHARMACEUTICALS INC. | 2 | $38 |
| Esperion Therapeutics, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| AtriCure, Inc. | 1 | $25 |
| Mannkind Corporation | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Attruby, FUROSCIX, NEXLETOL, VERQUVO, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, AFREZZA, OPSYNVI, CAMZYOS.
Industry payments across GA — which companies pay providers there.
